Skip to main content

Animations

MJFF Publications

4241 - 4250 of 8816 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2020
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-25060-1
    Citation Count: 59
  • Summary Details
    OPEN
    Title: A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02349-5
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-021-00872-x
    Citation Count: 57
  • Summary Details
    OPEN
    Title: C9orf72-G4C2 Intermediate Repeats and Parkinson’s Disease; A Data-Driven Hypothesis
    Journal Name: Genes
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/genes12081210
    Citation Count: 3
  • Summary Details
    OPEN
    Title: A comparison of prediction approaches for identifying prodromal Parkinson disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0256592
    Citation Count: 8
  • Summary Details
    OPEN
    Title: A pipeline for RNA-seq based eQTL analysis with automated quality control procedures
    Journal Name: BMC Bioinformatics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12859-021-04307-0
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Longitudinal observational study of boxing therapy in Parkinson’s disease, including adverse impacts of the COVID-19 lockdown
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-021-02359-6
    Citation Count: 11
  • Summary Details
    OPEN
    Title: miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-020-02185-z
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2257
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2220
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.